Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-11-01FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for a generic quetiapine fumarate product from Aurobindo Pharma Limited, enabling its use as a g…
-
CLINICAL_TRIALS trial_result · 2021-10-26Clinical Trial Update: Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD) [Phase 3]
A Phase 3 trial evaluating an oral aripiprazole/escitalopram combination for major depressive disorder was terminated; results were posted i…
-
CLINICAL_TRIALS trial_result · 2021-10-26Clinical Trial Update: Investigating Compassion-Based Guided Self-Help for Depression in People With Skin Conditions [NA]
A completed clinical trial assessing compassion-based guided self-help for depression in people with dermatologic conditions; results posted…
-
CLINICAL_TRIALS trial_result · 2021-10-20Clinical Trial Update: Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD) [Phase 3]
Phase 3 study evaluating an oral aripiprazole/escitalopram combination for major depressive disorder was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-10-20Clinical Trial Update: The Therapeutic Effect of Transcranial Direct Current Stimulation on Depression in Parkinson's Disease [Phase 1, Phase 2]
A terminated Phase 1/2 clinical trial investigated the effect of transcranial direct current stimulation on depression in Parkinson's diseas…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-10-19Clinical Trial Update: Dynamics of Inflammation and Its Blockade on Motivational Circuitry in Depression [Phase 4]
Phase 4 trial investigating inflammation dynamics and blockade effects on motivational circuitry in depression has completed with posted res…
-
CLINICAL_TRIALS trial_result · 2021-10-19Clinical Trial Update: UH3 Pragmatic Suicide Prevention Trial [NA]
A pragmatic UH3 trial update on suicide prevention in depression and suicidal ideation; study completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-10-15Clinical Trial Update: The Efficacy And Safety Of Mitizodone Phosphate Tablets In The Treatment of Patient With Major Depressive Disorder [Phase 2, Phase 3]
A clinical trial update on Mitizodone Phosphate Tablets for Major Depressive Disorder spanning Phase 2 and Phase 3, with unknown status.
-
CLINICAL_TRIALS trial_result · 2021-10-14Clinical Trial Update: Improving South African Government Workers' Capacities to Deliver HIV Interventions [Phase 2, Phase 3]
Phase 2/3 clinical trial update assessing interventions to improve delivery of HIV-related interventions among South African government work…
-
CLINICAL_TRIALS research · 2021-10-12Clinical Trial Update: Adjunctive Treatment of Major Depression Utilizing Auricular Acupuncture [NA]
A completed clinical trial evaluating adjunctive auricular acupuncture for major depressive disorder; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-10-07Clinical Trial Update: Social Connections and Late Life Suicide [NA]
Completed clinical trial investigating social connections and late-life suicide; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-10-05Clinical Trial Update: Automatic Self Transcending Meditation Versus Treatment as Usual [NA]
Completed clinical trial comparing Automatic Self Transcending Meditation to treatment as usual for Major Depressive Disorder; results poste…
-
CLINICAL_TRIALS trial_result · 2021-10-04Clinical Trial Update: The Relationship Among Changes in Brain Network Activation in Adult Outpatients With Major Depressive Disorder [Phase 4]
Phase 4 clinical trial update examining changes in brain network activation in adults with major depressive disorder; results posted after c…
-
FDA approval · 2021-10-04FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (Alvogen, Inc.)
FDA approves the sertraline hydrochloride generic under an Original Application filed by Alvogen, Inc. The approval enables marketing of a g…
-
FDA approval · 2021-09-29FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (AiPing Pharmaceutical, Inc.)
FDA approved a supplemental application for Amitriptyline Hydrochloride, a generic product submitted by AiPing Pharmaceutical, Inc., under t…
-
CLINICAL_TRIALS trial_result · 2021-09-24Clinical Trial Update: Assessing Symptomatic Clinical Episodes in Depression [Phase 2]
Phase 2 clinical trial assessing symptomatic clinical episodes in major depressive disorder has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-09-23Clinical Trial Update: Comparison of Orcinoside With Placebo in Treatment of MDD [Phase 2]
Phase 2 trial comparing Orcinoside with placebo for major depressive disorder has completed.
-
FDA approval · 2021-09-21FDA Approved: CITALOPRAM — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
The FDA approved a supplemental application for Citalopram (generic) from Chartwell Governmental & Specialty RX, LLC.
-
FDA approval · 2021-09-21FDA Approved: FLUOXETINE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for Fluoxetine Hydrochloride from Lannett Company, Inc., a generic fluoxetine product.
-
FDA approval · 2021-09-21FDA Approved: FLUOXETINE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC)
FDA approved a supplemental application for fluoxetine submitted by Chartwell Governmental & Specialty RX, LLC.
-
FDA approval · 2021-09-21FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Venlafaxine (venlafaxine hydrochloride) from BluePoint Laboratories, confirming the approval of …
-
FDA approval · 2021-09-21FDA Approved: VENLAFAXINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for venlafaxine from Sun Pharmaceutical Industries (ANDA078627).
-
FDA approval · 2021-09-21FDA Approved: VENLAFAXINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for a generic Venlafaxine manufactured by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceutica…
-
FDA approval · 2021-09-21FDA Approved: FLUOXETINE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for fluoxetine hydrochloride submitted by PAI Holdings, LLC dba PAI Pharma. The approval updates the…
-
FDA approval · 2021-09-21FDA Approved: ESCITALOPRAM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for escitalopram oxalate (escitalopram) from Sun Pharmaceutical Industries, expanding access to a ge…